Identification and characterization of secreted effector proteins of Chlamydophila pneumoniae TW183

Research in Microbiology

Volumn 157, Issue 6, 2006, Pages 513-524

  Herrmann, Michael ^a   Schuhmacher, Alexander ^a   Mühldorfer, Inge ^a   Melchers, Klaus ^b   Prothmann, Christian ^b   Dammeier, Sascha ^a  

^a ALTANA PHARMA AG   (Germany)

^b ALTANA Research Institute   (United States)

Author keywords

Chlamydia; Effector; Secretion

Indexed keywords

ANTISERUM; IMMUNOPHILIN; MEMBRANE PROTEIN; TACROLIMUS;

ARTICLE; BIOINFORMATICS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; GENE CLUSTER; GENE LOCATION; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFECTION; LEGIONELLA; MACROPHAGE; MEMBRANE MARKER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

BACTERIAL PROTEINS; CELL LINE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMPUTATIONAL BIOLOGY; HUMANS; IMMUNE SERA; MEMBRANE PROTEINS; PHOSPHOPROTEINS;

CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; LEGIONELLA;

EID: 33745999156     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2005.12.005     Document Type: Article

References (73)

1. Al-Younes H.M., Rudel T., Brinkmann V., Szczepek A.J., and Meyer T.F. Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell. Microbiol. 3 (2001) 427-437
2. Altschul S.F., Gish W., Miller W., Meyers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
3. Beatty W.L., Belanger T.A., Desai A.A., Morrison R.P., and Byrne G.I. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62 (1994) 3705-3711
4. Beatty W.L., Byrne G.I., and Morrison R.P. Morphologic and antigenic characterization of interferon {gamma}-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90 (1993) 3998-4002
5. Belland R.J., Scidmore M.A., Crane D.D., Hogan D.M., Whitmire W., McClarty G., and Caldwell H.D. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. USA 98 (2001) 13984-13989
6. Büttner D., and Bonas U. Port of entry-the type III secretion translocon. Trends Microbiol. 10 (2002) 186-192
7. Chang J.J., Leonard K.R., and Zhang Y.X. Structural studies of the surface projections of Chlamydia trachomatis by electron microscopy. J. Med. Microbiol. 46 (1997) 1013-1018
8. Cianciotto N., Eisenstein B.I., Engleberg N.C., and Shuman H. Genetics and molecular pathogenesis of Legionella pneumophila, an intracellular parasite of macrophages. Mol. Biol. Med. 6 (1989) 409-424
9. Cianciotto N.P., Eisenstein B.I., Mody C.H., and Engleberg N.C. A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J. Infect. Dis. 162 (1990) 121-126
10. Cianciotto N.P., and Fields B.S. Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages. Proc. Natl. Acad. Sci. USA 89 (1992) 5188-5191
11. Clifton D.R., Fields K.A., Grieshaber S.S., Dooley C.A., Fischer E.R., Mead D.J., Carabeo R.A., and Hackstadt T. From the cover: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Nat. Acad. Sci. USA 101 (2004) 10166-10171
12. Coombes B.K., and Mahony J.B. Identification of MEK- and phosphoinositide 3-kinase-dependent signaling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell. Microbiol. 4 (2002) 447-460
13. Cornelis G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell. Biol. 3 (2002) 742-752
14. Dalhoff K., Kothe H., Maass M., and Katus H.A. Clinical relevance of Chlamydia pneumoniae infection-from the respiratory tract to the vascular system. Pneumologie 54 (2000) 517-524
15. Durocher D., and Jackson S.P. The FHA domain. FEBS Lett. 513 (2002) 58-66
16. Durocher D., Taylor I.A., Sarbassova D., Haire L.F., Westcott S.L., Jackson S.P., Smerdon S.J., and Yaffe M.B. The molecular basis of FHA domain: Phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol. Cell. 6 (2000) 1169-1182
17. Ehrbar K., Friebel A., Miller S.I., and Hardt W.D. Role of the Salmonella pathogenicity island 1 (SPI-1) protein InvB in type III secretion of SopE and SopE2, two Salmonella effector proteins encoded outside of SPI-1. J. Bacteriol. 185 (2003) 6950-6967
18. Engel J. Tarp and Arp: How Chlamydia induces its own entry. Proc. Nat. Acad. Sci. USA 101 (2004) 9947-9948
19. Fawaz F.S., van O., Homola E., Mutka S.C., and Engel J.N. Infection with Chlamydia trachomatis alters the tyrosine phosphorylation and/or localization of several host cell proteins including cortactin. Infect. Immun. 65 (1997) 5301-5308
20. Fields K.A., and Hackstadt T. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol. Microbiol. 38 (2000) 1048-1060
21. Fields K.A., Fischer E.R., Mead D.J., and Hackstadt T. Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J. Bacteriol. 187 (2005) 6466-6478
22. Gordon V.M., Leppla S.H., and Hewlett E.L. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 56 (1988) 1066-1069
23. Gordon V.M., Young Jr. W.W., Lechler S.M., Gray M.C., Leppla S.H., and Hewlett E.L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis: Different processes for interaction with and entry into target cells. J. Biol. Chem. 264 (1989) 14792-14796
24. Grayston J.T. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Red. 43 (1992) 317-323
25. Grayston J.T., and Wang S. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132 (1975) 87-105
26. Gruenheid S., Sekirov I., Thomas N.A., Deng W., Donnell P., Goode D., Li Y., Frey E.A., Brown N.F., Metalnikov P., Pawson T., Ashman K., and Finlay B.B. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 51 (2004) 1233-1249
27. Hacker J., and Fischer G. Immunophilins: Structure-function relationship and possible role in microbial pathogenicity. Mol. Microbiol. 10 (1993) 445-456
28. Hanks S.K., Quinn A.M., and Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241 (1988) 42-52
29. Hansen W., and Hensel M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect. 3 (2001) 549-559
30. Heuer D., Brinkmann V., Meyer T.F., and Szczepek A.J. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell. Microbiol. 5 (2003) 315-322
31. Ho T.D., and Starnbach M.N. The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells. Infect. Immun. 73 (2005) 905-911
32. Hotson A., Chosed R., Shu H., Orth K., and Mudgett M.B. Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol. Microbiol. 50 (2003) 377-389
33. Hsia R.C., Pannekoek Y., Ingerowski E., and Bavoil P.M. Type III secretion genes identify a putative virulence locus of Chlamydia. Mol. Microbiol. 25 (1997) 351-359
34. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62 (1998) 379-433
35. Kauppinen M., and Saikku P. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment. Clin. Infect. Dis. 21 Suppl. 3 (1995) S244-S252
36. Köhler R., Fanghanel J., Konig B., Luneberg E., Frosch M., Rahfeld J.U., Hilgenfeld R., Fischer G., Hacker J., and Steinert M. Biochemical and functional analyses of the Mip protein: Influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila. Infect. Immun. 71 (2003) 4389-4397
37. Kröll M., Klucken A.C., Wuppermann F.N., Fuhrmann O., Magerl C., Seybold J., Hippenstiel S., Hegemann J.H., Jantos C.A., and Suttorp N. Signal transduction pathways activated 12 in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol. 162 (1999) 4834-4841
38. Leonard C.J., Aravind L., and Koonin E.V. Novel families of putative protein kinases in bacteria and archaea: Evolution of the "eukaryotic" protein kinase superfamily. Genome Res. 8 (1998) 1038-1047
39. Lloyd S.A., Forsberg A., Wolf W., and Francis M.S. Targeting exported substrates to the Yersinia TTSS: Different functions for different signals?. Trends Microbiol. 9 (2001) 367-371
40. Ludwig B., Rahfeld J., Schmidt B., Mann K., Wintermeyer E., Fischer G., and Hacker J. Characterization of Mip proteins of Legionella pneumophila. FEMS Microbiol. Lett. 118 (1994) 23-30
41. Lugert R., Kuhns M., Polch T., and Gross U. Expression and localization of type III secretionrelated proteins of Chlamydia pneumoniae. Med. Microbiol. Immunol. (Berlin) 193 (2003) 163-171
42. Lundemose A.G., Kay J.E., and Pearce J.H. Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. Mol. Microbiol. 7 (1993) 777-783
43. Lundemose A.G., Rouch D.A., Birkelund S., Christiansen G., and Pearce J.H. Chlamydia trachomatis Mip-like protein. Mol. Microbiol. 6 (1992) 2539-2548
44. Mahony J.B. Chlamydiae host cell interactions revealed using DNA microarrays. Ann. N. Y. Acad. Sci. 975 (2002) 192-201
45. Matsumoto A. Electron microscopic observations of surface projections and related intracellular structures of Chlamydia organisms. J. Electron. Microsc. (Tokyo) 30 (1981) 315-320
46. Molle V., Kremer L., Girard B., Besra G.S., Cozzone A.J., and Prost J.F. An FHA phosphoprotein recognition domain mediates protein EmbR phosphorylation by PknH, a Ser/Thr protein kinase from Mycobacterium tuberculosis. Biochemistry 42 (2003) 15300-15309
47. Montigiani S., Falugi F., Scarselli M., Finco O., Petracca R., Galli G., Mariani M., Manetti R., Agnusdei M., Cevenini R., Donati M., Nogarotto R., Norais N., Garaguso I., Nuti S., Saletti G., Rosa D., Ratti G., and Grandi G. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect. Immun. 70 (2002) 368-379
48. Moulder J.W. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55 (1991) 143-190
49. Müller S., Feldman M.F., and Cornelis G.R. The Type III secretion system of Gram-negative bacteria: A potential therapeutic target?. Expert Opin. Ther. Targets 5 (2001) 327-339
50. Nichols B.A., Setzer P.Y., Pang F., and Dawson C.R. New view of the surface projections of Chlamydia trachomatis. J. Bacteriol. 164 (1985) 344-349
51. Paetzel M., Karla A., Strynadka N.C., and Dalbey R.E. Signal peptidases. Chem. Rev. 102 (2002) 4549-4580
52. Pallen M., Chaudhuri R., and Khan A. Bacterial FHA domains: Neglected players in the phosphothreonine signaling game?. Trends Microbiol. 10 (2002) 556-563
53. Pantoja L.G., Miller R.D., Ramirez J.A., Molestina R.E., and Summersgill J.T. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect. Immun. 69 (2001) 7927-7932
54. Read T.D., Brunham R.C., Shen C., Gill S.R., Heidelberg J.F., White O., Hickey E.K., Peterson J., Utterback T., Berry K., Bass S., Linher K., Weidman J., Khouri H., Craven B., Bowman C., Dodson R., Gwinn M., Nelson W., DeBoy R., Kolonay J., McClarty G., Salzberg S.L., Eisen J., and Fraser C.M. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28 (2000) 1397-1406
55. Rockey D.D., Chesebro B.B., Heinzen R.A., and Hackstadt T. A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis-cloning and characterization of the C. psittaci mip-like gene. Microbiology 142 Pt 4 (1996) 945-953
56. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., and Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 (1988) 983-986
57. A. Schuhmacher, Molekulargenetische Untersuchungen zur Pathophysiologie von Chlamydien (German), Dissertation, Universität Konstanz, Hartung-Gorre Verlag, Konstanz, 2001
58. Shi L., Potts M., and Kennelly P.J. The serine, threonine, and/or tyrosine-specific protein kinases and protein phosphatases of prokaryotic organisms: A family portrait. FEMS Microbiol. Rev. 22 (1998) 229-253
59. Slepenkin A., Motin V., de la Mazza L.M., and Peterson E.M. Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect. Immun. 71 (2003) 2555-2562
60. Slepenkin A., de la Maza L.M., and Peterson E.M. Interaction between components of the type III secretion system of Chlamydiaceae. J. Bacteriol. 187 (2005) 473-479
61. Stenner L., Liewen H., Zapata J.M., Pawlowski K., Godzik A., and Reed J.C. CADD, a Chlamydia protein that interacts with death receptors. J. Biol. Chem. 277 (2002) 9633-9636
62. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R.L., Zhao Q., Koonin E.V., and Davis R.W. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282 (1998) 754-759
63. Subtil A., Blocker A., and Dautry V. Type III secretion system in Chlamydia species: Identified members and candidates. Microbes Infect. 2 (2000) 367-369
64. Subtil A., Delevoye C., Balana M.E., Tastevin L., Perrinet S., and Dautry-Varsat A. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol. Microbiol. 56 (2005) 1636-1647
65. Subtil A., Parsot C., and Dautry V. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39 (2001) 792-800
66. Vandahl B.B., Birkelund S., and Christiansen G. Proteome analysis of Chlamydia pneumoniae. Meth. Enzymol. 358 (2002) 277-288
67. Vandahl B.B., Birkelund S., Demol H., Hoorelbeke B., Christiansen G., Vandekerckhove J., and Gevaert K. Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 22 (2001) 1204-1223
68. Vandahl B.B., Stensballe A., Roepstorff P., Christiansen G., and Birkelund S. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell. Microbiol. 7 (2005) 825-836
69. Verma A., and Maurelli A.T. Identification of two eukaryote-like serine/threonine kinases encoded by Chlamydia trachomatis serovar L2 and characterization of interacting partners of Pkn1. Infect. Immun. 71 (2003) 5772-5784
70. Yahr T.L., Vallis A.J., Hancock M.K., Barbieri J.T., and Frank D.W. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. USA 95 (1998) 13899-13904
71. Zhong G., Fan P., Ji H., Dong F., and Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exper. Med. 193 (2001) 935-942
72. Zhong G., Fan T., and Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exper. Med. 189 (1999) 1931-1938
73. Zhong G., Liu L., Fan T., Fan P., and Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J. Exper. Med. 191 (2000) 1525-1534